Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
974.9500 -3.85 (-0.39%)
NSE Jun 13, 2025 15:31 PM
Volume: 1.0M
 

logo
Zydus Lifesciences Ltd.
15 Feb 2023, 12:00AM
974.95
-0.39%
KRChoksey
In Q3FY23, ZYDUSLIF reported strong growth across businesses. The company’s key markets i.e. India and the US, have reported double digit growth of 12.5% and 29.3% respectively. The Indian business revenue was at INR 16436mn up 13% YoY. The Indian formulation business registered revenues of INR 12316mn and contributed around 30% of consolidated revenues (excluding COVID related issues).
Zydus Lifesciences L.. has an average target of 1024.00 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended